Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 12, 2019 - Issue 7
Submit an article Journal homepage
411
Views
4
CrossRef citations to date
0
Altmetric
Review

Changing the treatment paradigm for Parkinson’s disease psychosis with pimavanserin

Kelly E. LyonsDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, USACorrespondence[email protected]
View further author information
,
Rajesh PahwaDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, USAView further author information
,
Neal HermanowiczDepartment of Neurology, University of California Irvine, Irvine, CA, USAView further author information
,
Thomas DavisDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USAView further author information
,
Fernando PaganDepartment of Neurology, Georgetown University Medical Center, Washington, DC, USAView further author information
&
Stuart IsaacsonParkinson’s Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL, USAView further author information
Pages 681-691 | Received 28 Feb 2019, Accepted 22 May 2019, Published online: 13 Jun 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Laura Orsolini, Domenico De Berardis & Umberto Volpe. (2020) Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opinion on Drug Safety 19:8, pages 981-998.
Read now
Kun Hu, Meiju Zhang, Dongdong Wu, Yuxuan Xie & Jie Ren. (2020) A Novel Synthesis of Pimavanserin: A Selective Serotonin 5-HT2A Receptor Inverse Agonist. Organic Preparations and Procedures International 52:1, pages 69-76.
Read now

Articles from other publishers (2)

Stuart H. Isaacson, Mark GoldsteinRajesh PahwaCarlos SingerKevin KlosMichael Pucci, Yi ZhangDavid CrandallKenneth S. KoblanBradford Navia. (2023) Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT 1A Agonist, in Patients With Parkinson Disease Psychosis . Neurology Clinical Practice 13:4.
Crossref
Biljana Nigović. (2023) New approach on sensitive analysis of pimavanserin, levodopa and entacapone based on synergistic effect of graphene nanoplatelets and graphitized carbon nanotubes in functionalized polymer matrix. Electrochimica Acta 439, pages 141700.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.